Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03268759 · ClinicalTrials.gov registry record
Development of Reward Processing in Prenatally Exposed Adolescents and Young Adults
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 78
- Enrollment target
NCT03268759 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 78 participants.
The verdict
NCT03268759 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
Reward processing will be examined in prenatally exposed emerging adults in a longitudinal design. Participants will be followed for one year to see if neural markers of reward processing prospectively predict risk-taking behavior.
Interventions
- OTHER fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2020-09-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03268759
The ClinicalTrials.gov registry entry for NCT03268759 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fMRI is the first listed.
NCT03268759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03268759 about?
NCT03268759 is a clinical study titled "Development of Reward Processing in Prenatally Exposed Adolescents and Young Adults". Reward processing will be examined in prenatally exposed emerging adults in a longitudinal design. Participants will be followed for one year to see if neural markers of reward processing prospectively predict risk-taking behavior.
What is the current status of trial NCT03268759?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2017-09-15. Estimated completion is 2020-09-14.
What interventions are being tested in trial NCT03268759?
The interventions under investigation include: fMRI (OTHER).
Who is sponsoring clinical trial NCT03268759?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.